This is a one-year fellowship program in molecular genetic pathology accredited by the Accreditation Council for Graduate Medical Education (ACGME). Memorial Sloan Kettering Cancer Center also offers ACGME-accredited training programs in pathology, providing the appropriate academic environment for training in molecular genetic pathology.
The Laboratory of Diagnostic Molecular Pathology performs more than 10,000 diagnostic assays annually. Fellows will receive training in the performance and interpretation of various molecular diagnostic tests, including next-generation sequencing technologies, in the diagnosis of cancer and inherited disorders as well as monitoring of bone marrow transplant engraftment. While the program covers all areas of MGP training, fellows will gain exceptional training in cancer-related somatic and germline genetic testing. With the inclusion in the training of an affiliated clinical laboratory at NewYork-Presbyterian Hospital/Weill Cornell Medical Center that performs pediatric noncancer germline testing, the volume and variety of molecular testing for somatic and inherited genetic alterations and infectious diseases provide ample opportunity for fellows to become competent in the field of molecular genetic pathology. Additional in-house molecular microbiology rotation is provided. We estimate that each fellow is directly involved in approximately 4,000 cases over the course of the year. The fellows form a key element of the laboratory team and participate in bench work, review, interpretation, and discussion of test results. Test interpretation will take place under faculty supervision. Correlation with clinical and morphological parameters is stressed, and ample opportunity is given for participation in research projects. The fellowship may be used toward board-certification eligibility in molecular genetic pathology.
September 1 for online applications; September 15 for recommendation letters
Length of Program
The fellowship is available to individuals who have completed training in pathology in an ACGME-accredited residency program. Board eligibility in either anatomic pathology or anatomic pathology/clinical pathology is required prior to beginning the fellowship.
All qualified applicants are welcome, but preference will be given to those committed to an academic career in pathology. A definite attempt will be made to identify individuals interested in combining two pathology fellowships offered at Memorial Sloan Kettering under the assumption that this experience will provide them with a strong basis for a successful career in academic pathology.
Therefore, preference for the subspecialty fellowships and molecular pathology fellowships will be given to those who have completed the oncologic pathology fellowship at Memorial Sloan Kettering or those who have had an analogous experience at a similar institution.
Early application is encouraged.
Number of Positions
How to Apply
Once applicants have submitted their applications, they will need to send the following documents in order to be considered for a fellowship position:
- Three letters of recommendation from an institution in which the applicant has trained. These letters should be addressed to Dr. Snjezana Dogan.
- Copy of a medical school diploma and translation, if necessary.
- International medical school graduates must submit a copy of their Educational Commission for Foreign Medical Graduates (ECFMG) certificate that is marked “valid indefinitely.”
Molecular Pathology Staff
Stipend and Maintenance
The stipend is commensurate with the year of the applicant’s postgraduate training. Nearby housing is available with rents that are comparable to NYC market rates; professional liability insurance and health coverage are provided free of charge.
Memorial Hospital for Cancer and Allied Diseases is a 425-bed hospital devoted to the care of patients with neoplastic diseases. The hospital is part of Memorial Sloan- Kettering Cancer Center, which also includes the Sloan Kettering Institute. There is an affiliation and close interaction between the clinical and research units of Memorial Sloan Kettering and Weill Cornell Medical College, as well as with The Rockefeller University.